Royalty Pharma Plc (RPRX)
47.32
-1.25
(-2.57%)
USD |
NASDAQ |
Apr 06, 16:00
47.30
-0.02
(-0.03%)
After-Hours: 20:00
Royalty Pharma SG&A Expense (TTM) : 573.21M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Zymeworks, Inc. | 61.51M |
| Johnson & Johnson | 23.68B |
| Biogen, Inc. | 2.434B |
| Revolution Medicines, Inc. | 195.04M |
| Cytokinetics, Inc. | 284.27M |